Cost-Effectiveness Analysis of Conbercept Versus Ranibizumab For The Treatment of Age-Related Macular Degeneration In China

Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.558
https://www.valueinhealthjournal.com/article/S1098-3015(15)02634-0/fulltext
Title : Cost-Effectiveness Analysis of Conbercept Versus Ranibizumab For The Treatment of Age-Related Macular Degeneration In China
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)02634-0&doi=10.1016/j.jval.2015.09.558
First page : A421
Section Title : Research Podium Presentations - Session 1 and Session 2
Open access? : No
Section Order : 475
Categories :
Tags :
Regions :
ViH Article Tags :